Firehawk Clinical Data From The TARGET AC European Clinical Tr...
SHANGHAI, Sept. 4, 2018 /PRNewswire-AsiaNet/ -- MicroPort Scientific Corporation ("MicroPort(R)", HK:0853) announced today that the clinical trial results for its Firehawk(R) Rapamycin Target Eluting Coronary Stent System ("Firehawk(R)") which conducted a multi-center, randomized controlled tri...
Read more https://view-release/?pr-id=75004